Nemolizumab Antibody
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the interleukin-31 receptor A (IL-31RA), blocking IL-31 signaling. It is a key research tool for investigating the mechanisms of pruritus in atopic dermatitis, utilized in both in vitro binding assays and in vivo models of inflammatory skin disease.
Product Specifications
Product Name Alternative
CIM 331, CIM331, CIM-331, Nemolizumab, Interleukin Related
Target
Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.28 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.92 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1324305 3x 1.0 µg
MRGPRF sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
252042-AP 100 µL
SPG3A (atlastin GTPase 1, AD-FSP, FSP1, GBP3, SPG3, SPG3A, atlastin1) (AP) discontinued
Sign In for Pricing
View Details